Osaic Holdings
DRUG

Osaic Holdings’s Bright Minds Biosciences DRUG Stock Holding History

Osaic Holdings’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62K Buy
+80
New +$6.28K ﹤0.01% 6870
2026
Q1 		– Sell
-371
Closed -$29K – 7878
2025
Q4 		$29K Buy
+371
New +$24.8K ﹤0.01% 5611
2025
Q1 		– Sell
-175
Closed -$6.3K – 7509
2024
Q4 		$6.3K Buy
+175
New +$6.16K ﹤0.01% 6064
2022
Q4 		– Sell
-80
Closed – – 7235
2022
Q3 		$0 Buy
+80
New +$519 ﹤0.01% 7304

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Osaic Holdings's DRUG Position: Q2 2026 in Review

Osaic Holdings opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 80 shares worth $5.62K. The stake represents ﹤0.01% of the portfolio and ranks #6870 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in DRUG as recently as Q4 2025.

Osaic Holdings first reported a position in DRUG in Q3 2022 and has held it in 4 quarters since. The position peaked at $29K in Q4 2025. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Osaic Holdings held 80 shares of Bright Minds Biosciences worth $5.62K as of Q2 2026.
  • Bright Minds Biosciences was a new Osaic Holdings position in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6870 holding.
  • Osaic Holdings first reported a position in Bright Minds Biosciences in Q3 2022 and has held it in 4 quarters since.
  • Osaic Holdings's Bright Minds Biosciences position peaked at $29K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.